CAR-T半年狂销8亿美元,传奇生物的下一个爆点在哪?

医药魔方
17 Jul

7月16日晚间,强生的一份财报公开了传奇生物CAR-T细胞疗法的亮眼成绩。财报显示,CARVYKTI (西达基奥仑赛)上半年销售额达8.08亿美元。金斯瑞方面,根据传奇生物与Janssen Biotech,Inc.于2017年12月21日订立的合作及许可协议,截至2025年6月30日,Carvykti则产生贸易销售净额约4.39亿美元。早在去年,Carvykti的全年销售就已达9.63亿美元,其中...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10